Marije Havermans

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeability.

Massive barcode-free chemical screenings enable the discovery of bioactive macrocycles with passive membrane permeability.

Journal: Nature communications
Published: December 17, 2025

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Journal: Blood
Published: February 21, 2025

Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2.

Oncogene EVI1 drives acute myeloid leukemia via a targetable interaction with CTBP2.

Journal: Science advances
Published: May 15, 2024

Gata2-regulated Gfi1b expression controls endothelial programming during endothelial-to-hematopoietic transition.

Gata2-regulated Gfi1b expression controls endothelial programming during endothelial-to-hematopoietic transition.

Journal: Blood advances
Published: May 04, 2022

EVI1 drives leukemogenesis through aberrant ERG activation.

EVI1 drives leukemogenesis through aberrant ERG activation.

Journal: Blood
Published: April 06, 2022

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.

Journal: Blood
Published: December 28, 2021

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice.

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice.

Journal: Blood advances
Published: July 30, 2021

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

Journal: Nature communications
Published: June 10, 2021

Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.

Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.

Journal: Cancer discovery
Published: December 15, 2020

Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.

Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.

Journal: Blood
Published: October 11, 2019

An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.

An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.

Journal: Blood
Published: January 28, 2016

Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways.

Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways.

Journal: Blood
Published: November 09, 2014
Showing 1-12 of 16

Last Updated: 09/26/2026